Gilead Sciences, Inc. (BVMF:GILD34)
Brazil · Delayed Price · Currency is BRL 331.17
+6.43 (1.98%)
At close: Jan 15, 2026
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 807.71 billion as of January 16, 2026. Its market cap has increased by 13.00% in one year.
Market Cap
807.71B
Enterprise Value
884.81B
Revenue
155.02B
Ranking
n/a
PE Ratio
18.69
Stock Price
331.17
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 240.84M to 807.71B, an increase of 335,271.43%. That is a compound annual growth rate of 26.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 807.71B | -3.70% |
| Dec 31, 2025 | 838.76B | 17.81% |
| Dec 31, 2024 | 711.99B | 45.36% |
| Dec 29, 2023 | 489.80B | -13.96% |
| Dec 30, 2022 | 569.24B | 12.17% |
| Dec 31, 2021 | 507.47B | 33.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.76B |
| Raia Drogasil | 41.34B |
| Hypera | 14.96B |
| Fleury | 8.25B |
| Odontoprev | 5.73B |
| Diagnósticos da América | 5.24B |
| Empreendimentos Pague Menos | 4.26B |
| Oncoclínicas do Brasil Serviços Médicos | 2.93B |